Largest Proposed Insurance Merger Fuels Concerns, Questions About Consolidation

This morning, Anthem announced it is seeking to acquire Cigna, in a proposed $54.2 billion transaction. This deal would be the largest-ever health insurance transaction in the nation’s history. This announcement comes on the heels of two other grand-scale deals between some of the largest insurance companies in the country. As Modern Healthcare explained this morning, this series of deals has created a, “mass-scale merger race that is fundamentally changing the industry and fueling concerns over costs and competition.”

Indeed, analysts and reporters have been closely following this latest surge in insurer consolidation, assessing the implications of what it would mean to have just a handful of insurance companies serving all consumers.  A recent New York Times article outlined some of the core concerns linked to these deals:

  • -As insurers grow larger, will consumers benefit from the companies’ ability to bargain with hospitals and doctors for lower prices?
  • -Will diminishing competition translate to fewer choices of plans?
  • -And what effect will mergers have on innovation in health care?

Insurer consolidation is a decades-long trend that began in the 1990s, and has seen waves of increased activity over time. Today, we see trends among insurers that are alarming. The American Medical Association’s annual report on insurer consolidation has for several consecutive years reported a national scenario where just 1 or 2 insurers hold majority power in 47 states. This market power gives insurers leverage in negotiations with providers, and has impacted the paradigm shift in benefit plan design that shifts greater risk and cost-sharing responsibility to the consumer. Monopoly power is a major concern for regulators, as Modern Healthcare story explains:

A larger insurer can gain more leverage and negotiating power to use in hashing out rates with care providers. However, the two mega deals announced this month are going to be scrutinized heavily by regulators, who want to ensure that they do not gain so much power that they can dominate the market.

It is imperative that the all affected stakeholders ask the critical questions and voices their concerns as these deals are reviewed by regulators. We have the benefit of hindsight and a lengthy history of insurer consolidation to help clarify what is at stake for consumers and the health care industry as a whole if these mega-mergers are allowed to go through. All concerns and questions on the table are valid and should be vetted properly in tandem with the regulatory protocols before any proposed deals are finalized.

Leave a Reply

Your email address will not be published. Required fields are marked *